League tables are unreasonably simple
Editor-Not comparing like with like is the easy and traditional battle cry of those seeking to cast doubt on league tables of health service providers. It seems unfortunate therefore that the tables published for the benefit of the public in the Times as the hospital consultants' guide fall at the first hurdle on what seems to be a technical misuse, based on misleading comparisons, of one of the key statistics. 1 2 Ranking in the league tables is based on both standardised mortality ratios and death rates per 100 000, although these summarise some complex statistical workings. 3 Standardised mortality ratios are a seemingly well understood means of comparing the mortality of a local population with that of a wider population, taking into account the age and sex distribution. But the Times supplement misleadingly refers to a standardised figure for mortality ratios of 100 as the national average, a higher figure indicating a higher than average number of deaths. Although this statement might be broadly true, it is also likely to produce biased tables as it misrepresents standardised mortality ratios and misuses this statistic.
Comparing standardised mortality ratios seems intuitive and looks reasonable until one unpicks their construction. A standardised mortality ratio uses the exposed group as the standard, meaning that the wider or national group is not the standard, which is probably where the misperception occurs. Therefore, comparisons of standardised mortality ratios with one another are invalid unless the age and sex distributions of the populations concerned are similar. The extent of the bias in making these comparisons may be small unless there are reasonably large departures from this point, but we do not know how much this departure for any one population differs from another and contributes towards its position in the table. 3 This point has been raised before both in relation to Dr Foster's league tables and more generally. 4 5 It may be that Dr Foster's tables have some good statistical validity but I find it difficult to tell. There is a good argument to suggest that those participating in furthering public health with good information should stop using standardised mortality ratios. Often we try to represent highly complex issues with simple figures. In these cases we should either avoid using summary figures that require the statistical rules to be bent or acknowledge that simplifying to this sort of degree does not reflect the reality. 
Jonathan Howell consultant in public health medicine

Use of language should be more careful in describing league tables
Editor-As a cardiologist working in the hospital with the highest overall heart bypass mortality, I note the injudicious use of terms such as health ghettoes and excessive deaths in most commentaries on league tables. This use of language creates undue alarm among the public. 1 Hospitals with higher surgical mortality tend to be larger hospitals with a higher throughput of cases and surgeons who accept patients at higher risk. League tables can give a true picture only if all units adopt the same selection criteria and operate on similar patients. Each surgical centre and individual surgeon tends to adopt their own threshold for patients at high risk, which would affect the centre's overall mortality. Dr Foster claims that age has been taken into their model for adjusting standardised mortality. In reality, the Society of Cardiac Surgeons accepts that even highly sophisticated models cannot predict accurately operative mortality, in particular for the patients at higher risk. Dr Foster uses a model with simple variables, and one of many deficiencies in this model is that the data that define the degree of urgency of operations are not collected. Without deploying these variables for risk adjustment, they cannot claim that any deaths are excessive.
Statistics on non-emergency operations show that our surgeons are second to none in their skill. The higher overall mortality can be explained by the fact that we and the referring hospitals have asked our surgeons to operate on older patients at higher risk who have been turned down by other centres. We stand by our practice since we know that without an operation, these patients would have had a much lower chance of survival.
The immediate impact of publication of such league tables will lead to many such patients being turned down for surgery. Hospitals with lower mortality cannot be complacent, least of all proud, of their results, unless they can show that their surgeons are as willing to take on high risk cases. Most surgeons will now adopt more defensive practices turning away higher risk patients, and we will never find out how many patients will die or suffer as a result-their statistic will never appear in any league table. Elderly sick patients are particularly vulnerable.
If we have to live with league tables, Dr Foster should also publish detailed information of case mix and volume-a complete picture of patient profiles alongside surgical deaths to allow the public to make informed choices without undue alarm. There is a political agenda for openness, but funding of the NHS falls short of European averages and the proportion of this spent on information technology is not compatible with generating accurate information.
Being listed inappropriately low down in a league table creates anxiety for patients and relatives and is damaging for staff morale, recruitment, and retention. This is important given the current underprovision of cardiac services and our desire to fulfil the revascularisation targets of the national service framework. Additionally, there are implications for cardiological referral practice: patients at high risk will be denied operations as surgeons strive to keep their noses clean. 3 Region by region, maternity hospitals were listed in order of merit. Having undertaken a regional survey of maternity services, I am well aware of the complexity of comparing different hospitals' performances. On close inspection of the Dr Foster league tables I discovered that the published order of merit had been determined just by ranking hospitals according to the number of births per midwife per year, fewer births being classed as better.
Although adequate midwife staffing is not unimportant, it is absurd to grade the quality of care between hospitals on this single factor. Such a presentation is misleading to the point of irresponsibility. It could be argued that the fewer births per midwife per year might even indicate a hospital's unsatisfactory reputation. 
NHS is national but not uniform
Editor-The article by Adab et al on performance league tables for the NHS presents a good argument for the use of control charts in place of league tables. 1 Charts seem more understandable and are less likely to cause confusion. The statistical problems of league tables are well put and valid.
I disagree with Adab et al as the NHS cannot be regarded as a single uniform organisation. The data from Dr Foster identified that staffing levels greatly affect mortality. Trusts differ in their staff retention rates and policy, and they do not always attract the same quality of applicants. From this point of view, comparing one trust with another may be more similar to comparing Ford with Honda than looking at different units in the same company.
This does not detract from the use of control charts, but it is important not to view the NHS as adhering to a uniform pattern as trusts differ in their priorities, incentives, and abilities. As an outcome measure mortality is still too rare an event to be very sensitive and, no matter how it is presented, will therefore not be very informative. New more sensitive outcome measures need to be developed.
It is also a mistake to look at outcomes without looking at use of resources. As an example, if comparing two coronary bypass units it is not sufficient to know the mortality at 30 days for each unit without also calculating the costs per patient of each unit. This has been the gaping hole in most of the recent published data, including those from the Dr Foster team.
Tom Aslan partner in general practice 1 Binfield Rd, London SW4 6TB t.aslan@lse.ac.uk This safety net is likely to be perceived as positive by the patient, who may feel even more empowered as the doctor has clearly planned for the uncertainty that all patients know exists. Pretending to know the future or exact diagnosis fools no one and is likely to lessen satisfaction and empowerment. Helping patients to handle uncertainty effectively is an important part of enablement. This clarification of what is meant by a positive approach should be addressed in future research.
David Shepherd general practice principal
Saffron Group Practice, Leicester LE2 6UL daveshep@fish.co.uk 
Partnership of patient and doctor may provide key to patient satisfaction
Editor-The observational study by Little et al of the effects of patient centredness on the outcomes of consultations in general practice is empirically rich and informative. 1 We would like to comment on the way studies such as this construct a dyadic model that implicitly presumes that the doctor bears the major responsibility for patient satisfaction. Social research with HIV positive people in Australia suggests an alternative approach in which doctors and patients are seen as agents operating in clinical space that is wider than the consultation. 2 3 Although this research has specific contextual limits, it also suggests a way forward that allows increased expertise on the part of the patient to be taken seriously and engages with the changing ways that medical knowledge circulates in the wider society, including the media.
The consultation is a key element in the constitution of clinical space, but it is not definitive of it. HIV positive people in Australia rely heavily on specialist HIV general practitioners for information about their pharmaceutical treatments, but they distinguish between information and wider perspectives on living with HIV. 4 Their negotiation of decisions about treatment occurs in a framework of self care. Patients may pre-empt the consultation at different times and on different issues. For example, decisions about adherence, drug holidays, and the use of recreational drugs seem to be made in the context of mostly well informed self care practices rather than on the basis of a clinical consultation alone.
We are currently exploring the ways in which some of these decisions come home to roost in the consultation and how self care and self harm are understood. If we locate interactions between doctors and patients in an expanded notion of clinical space then both doctors' and patients' perceptions of what is possible in a brief consultation and doctors' expectations of themselves can be shifted into a more productive understanding of how self care occurs. Focusing solely on the consultation increases the pressure and the likelihood of dissatisfaction with the doctor and the practice of medicine.
Patients exercise an increasingly well informed medical gaze as an ordinary part of everyday life. Expecting or requiring doctor consultations to be responsible for all aspects of this by measuring quantifiable units of practice without querying the realism of patients' expectations reinforces the pressures on the consultation. Counsels of perfectibility tend to produce resentment and lower self-esteem, adding to the desire to leave general practice. 5 We think that a wider understanding of clinical space and cultures of care allows recognition of the productivity of consultations, even as the inherent challenges are acknowledged. 
Michael Hurley
Somatisation in primary care
Solitary disclosure allows people to determine their own dose
Editor-On the surface, Schilte et al in their study suggest that disclosure of emotional events has no effect on markers of physical health or health related behaviours-a finding at odds with studies published over the past few years. [1] [2] [3] A critical difference between the study by Schilte et al and most other disclosure studies is that Schilte et al required participants to talk about a traumatic experience to another person. Most successful disclosure studies, on the other hand, have had participants write anonymously about a trauma for several days in a laboratory, in a neutral setting, or at home.
The study may help show when disclosure can be helpful versus harmful. It may also address recent controversies surrounding critical incident stress debriefing, where people who have experienced recent trauma are pressed to talk about their emotions to people in the context of a group. An increasing number of controlled tests of techniques wherein people have been asked to talk about emotional upheavals to others have found this form of debriefing either to be unhealthy or to have no effect. 4 Having to deal with deeply emotional topics in a social setting forces the listener to help regulate what is and is not said. The social pressure of talking to an "expert" may invite embarrassment or humiliation on the part of the patient. When people are writing or talking into a tape recorder by themselves, they are able to determine how much they are willing to disclose. In short, solitary disclosure allows people to determine their own dose.
Schilte et al suggest that it is not in the physician's or patient's best interest to encourage the deep disclosure of highly traumatic experiences. Separate, equally controlled projects should address whether disclosure in alternative ways (for example, disclosive writing) may bring about the beneficial effects that Schilte et al were originally predicting. 2 Somatisation is a much broader phenomenon than is reflected in the categories of official diagnostic classifications. The operational definition of somatising patients in the paper by Schilte et al, on the basis of previous studies from Escobar's group, is interesting since most patients with unexplained symptoms do not meet the high threshold of symptoms for somatoform disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). 3 The criteria for undifferentiated somatoform disorder are, however, overly inclusive.
Descriptive use of term should not be confused with its conceptualisation
Some reasons could be elicited for explaining the absence of effect of the disclosure intervention on the health of somatising patients, including the brief period of intervention and the high prevalence of anxiety and depressive disorders found by Schilte et al. Another possible reason is that different treatment interventions must be designed to treat patients with different levels of distress. 4 Despite that, somatisation includes a heterogeneous population, and the descriptive use of the term should not be confused with its conceptualisation. Some support the concept of somatisation as the expression of personal distress in an idiom of bodily complaints with medical help seeking behaviour as adopted in the paper, but others have emphasised the need to define the concept clearly, encompassing coping style and personality traits. The effectiveness of treatment strategies derived from such conceptualisations, such as promoting verbal expression of emotions or psychological conflicts in alexithymic patients, has not been shown. 5 The study by Schilte et al confirms this. 
Author's reply
Editor-Pennebaker's theory that written expression is superior to the talking methods applied by us may explain the difference between our negative findings and other positive studies on disclosure. Some other articles on the effect of disclosure through talking did, however, show an effect, although, as Pennebaker points out, this was not as impressive as in written and anonymous disclosure. 1 Somatisation is an interactive problem. For that reason we chose talking rather than anonymous writing, with the aim of extending the outcome of the talks to the relationship between patient and general practitioner. This may have influenced what patients disclosed. The intervention was offered by us in an open inviting way, reflecting sincere interest in the patient's story and following the patient's frame of reference. Most patients believed that they had disclosed important information and liked the meetings.
We explained our contrasting findings by the difference in the groups of patients studied. Many patients in our study had had problematic childhoods and life stories and were mostly of a lower socioeconomic and educational background. Patterns of healthcare behaviour such as frequent attendance in primary care, a tendency to explain symptoms with a disease model (with external locus of control), a wish to undergo further diagnostic procedures and referrals, and frequent use of symptomatic drugs (painkillers, tranquillisers), physiotherapy, and sick leave are often fixed. Frustration among doctors managing these patients, resulting in patients not being taken seriously and being given a quick prescription or referral, can add further to the somatisation process. 2 Disclosure through writing or talking can be helpful but does not effectively change the patterns of somatisation, which reflect the healthcare behaviour of patients and their physicians.
Teixeira and Alvarenga-Silva responded to our article from a psychiatric point of view. Somatisation as operationalised by us according to the criteria of Escobar should certainly not be classified as a psychiatric disorder. Most people have episodes with physical complaints that are not explained by organic disease. Low grade somatisation is common, especially in primary care (one in 20 patients) and created at least 20% of the workload of the general practitioners in our study. Effective strategies for somatisation are needed that are not too complex for general practitioners to apply.
An ideal long term disclosure intervention would encompass many contacts with the patient. But patients willing to participate in such long term psychological interventions will visit psychiatrists, psychologists, or social workers, who are better trained. In the Netherlands, most patients, however, are managed by general practitioners, who will usually not be able to find the time for psychological interventions requiring a larger number of contacts. 
Quality of Cochrane reviews
Quality of Cochrane reviews is better than that of non-Cochrane reviews
Editor-Olsen et al assessed a sample of Cochrane reviews from 1998 and highlighted some areas where improvement is possible. 1 They found that 29% of reviews had major problems, including inappropriate methods and conclusions. As they say, improvement is still possible, but this figure nevertheless represents a major improvement on the quality of non-Cochrane reviews.
We have reviewed the methods of 480 systematic reviews on the database of abstracts of reviews of effectiveness (DARE) at the University of York. 2 3 Methodological details of the reviews were coded and checked by two reviewers working independently. We found that only half (52%) of the reviews had systematically assessed the validity of the included studies; that most systematic reviews were unlikely to be comprehensive (they had searched either one or two databases); and that overall only a quarter (26%) of reviews met three key methodological criteria (relating to a thorough search, assessment of the validity of the included studies, and investigation of heterogeneity). Narrative reviews were less likely to meet all three criteria (20% v 30%, P = 0.02) and more likely to be coded by raters as inconclusive.
Up to half of non-Cochrane reviews are thus potentially misleading. Against this, Olsen et al's estimate of 29% for Cochrane reviews compares favourably. Although more recent research syntheses are likely to be of higher quality, particularly if reviewers follow current guidelines, 4 5 problems with the reliability of systematic reviews will probably remain. Since our study was conducted the criteria for including systematic reviews on the database of abstracts of reviews of effectiveness have been revised (from October 2000 onwards) to ensure that only reviews of potentially high methodological quality are included.
We would support Olsen et al's suggestion that users of any systematic review should assess its reliability. We would also recommend that for a critical assessment of the quality of non-Cochrane reviews users should first look at the database of abstracts of reviews of effectiveness.
Another study found that most Cochrane reviews are of a good standard Editor-We would extend Olsen et al's observations on Cochrane reviews. 1 Last year we undertook a study of the utility of the Cochrane Database of Systematic Reviews in informing health policy and practice. 2 We produced summary documents listing the conditions or diseases reviewed; the statements of evidence and effect; and, where available, conclusions for policy and practice for the reviews from collaborative review groups that covered cancer (including tobacco addiction), vascular disease, and fractures. In assessing the Cochrane reviews we scrutinised high profile sections (review title, abstract, objectives, conclusions, synopsis), just as a busy healthcare professional would do.
When necessary we inspected other sections of the review. Although we did not critically appraise review methodology, we recorded any errors, discrepancies (including discordance between the conclusions of effect and the available evidence), and other items needing clarification. We reported such information direct to the coordinators of the collaborative review groups.
We sent specific comments on 62 of the 159 reviews processed in Issue 2, 2000, of the Cochrane Library. Although most comments were minor, the inappropriate interpretation of results leading to spurious conclusions was considered likely in two reviews, the disregard of problems with the unit of analysis was thought likely in four, and sections were missing in two. Failure to collect outcome data on adverse effects of treatment and quality of life and function was also commented on in several reviews.
Our experience confirms that most Cochrane reviews are of a good standard. This is a considerable achievement, especially given the unpaid and voluntary nature of the work. The regularly updated electronic publication and the comments and criticisms facility offer great advantages. For instance, in cases where reviews with serious defects cannot be remedied speedily their temporary removal is important. Like Olsen et al, we emphasise the importance of feedback from users of the Cochrane Library.
Finally, Olsen et al conclude that readers should themselves assess the reliability of individual Cochrane reviews, and they emphasise the need to learn the skills of critical appraisal. We support their recommendation, but we are concerned that this may seem like advice to let the buyer beware. Given the broad readership (including lay people) of Cochrane reviews, the main emphasis must be on good quality and reliable reviews that people can trust. Moreover, the confusion lasting for only 48 hours might have been the result of using antiemetics in a patient who had been vomiting almost hourly for 24 hours.
Helen Handoll research fellow, Hull University
2 Urine toxicology screening does not exclude this additional complication.
In the second case, exhaustive virological investigations and liver biopsy were not performed, and the metabolic screening is incomplete. In both patients the diagnosis of Reye's syndrome is therefore put forward-in the best case-by default.
We are surprised that McGovern et al ignore the misleading biases in the epidemiological studies suggesting a link between Reye's syndrome and aspirin. 2 3 The studies were performed on series of children with heterogeneous disorders, which already invalidates their results. In the studies that recorded correctly all drugs given before admission, the use of not one but two drugs was significant-namely, aspirin and antiemetics. 2 Neither is the decline of Reye's syndrome an argument for a link with aspirin; evidence shows that this decline is the result of medical progress leading to more correct diagnosis of infectious, metabolic, or toxic disease. 2 4 When promoting paracetamol and ibuprofen it would be wise not to conceal their side effects-for example, the hepatotoxicity of paracetamol, which can occur even at minor overdoses given during a few days. This was documented by Rivera-Penera et al and discussed in an accompanying editorial by Heubi and Bien, who assumed that the estimates of the occurrence of paracetamol toxicity are the tip of the iceberg of the total number of cases seen in the United States. 
Authors' reply
Editor-Neither nosology nor nomenclature should be regarded as static but as dynamic disciplines that evolve as understanding of causation and pathogenesis bear on clinical experience and its reporting. But Casteels-Van Daele et al go too far in saying that Reye's syndrome is no longer a clinicopathological entity but a term embracing heterogeneous, disparate disorders. On the contrary, increased understanding has come about by the adoption of a standardised definition that enables case ascertainmentepidemiology as a springboard for biological research. 1 In Northern Ireland children with encephalopathic illnesses are referred for investigation and management to a single tertiary unit, and paediatricians maintain a high degree of vigilance so that inherited metabolic disorders are unlikely to masquerade as Reye's syndrome or vice versa.
Remarkably few patients have been seen since 1986 (when the Committee on Safety of Medicines warned professionals against use of aspirin in children), by contrast with previous numbers. In 1979-80 there were nine; in 1981-82, 10; in 1983-84, 25; and in 1985-86,11. This action and continuing case surveillance has been rightly regarded as a triumph in primary prevention of a devastating childhood illness.
We appreciate that Reye's syndrome is not a single entity, but broad consensus remains that a major identifiable variant is associated with aspirin taken for the symptoms of febrile illness, of which our cases are examples. 2 Our primary concerns are in relation to warnings on sales over the counter, and the age limit above which aspirin is-erroneously, in our opinionregarded as safe. Another concern is case surveillance, especially in the event of further influenza outbreaks. With reference to the specific cases described, the first patient had not received any medicine except aspirin; antiemetics are not usually given in Northern Ireland for brief gastrointestinal upsets in children. Even if the patients had received alternative treatments, evidence linking drugs other than aspirin with Reye's syndrome has never been accepted or sustained. The other three patients seen between 1986 and 1998 were each atypical, had low Reye scores, and were not linked to use of either drug.
Clear thinking is crucial to understanding this spectrum of encephalopathy-Reye's-like syndromes associated with an inherited metabolic disorder, Reye's syndrome that meets the non-specific, diagnostic criteria, and "classic" (aspirin associated) Reye's syndrome that we must try to prevent. 1 2 We have demonstrated biological plausibility using cultured fibroblasts from recovered patients with Reye's syndrome. Salicylate within the therapeutic range and its metabolites reversibly inhibit activity of -oxidation at 3-hydroxyacyl-CoA dehydrogenase of the mitochondrial trifunctional enzyme-quite the opposite response to that found in control cells. 
Demand for prostate specific antigen testing in primary care
Screening through back passage as well as back door?
Editor-Donovan et al highlight the fact that current policy for testing amounts of prostate specific antigen (PSA) amounts to screening by the back door. 1 They do, however, overlook another insidious form of screening by PSA. Men who present with the well known prostatic type symptoms in primary care typically receive PSA testing as part of their work up, either from their general practitioner or after referral. But these symptoms are not good markers for prostate cancer-in fact, men with obstructive urinary symptoms are no more likely than men without symptoms to have prostate cancer. In other words, in terms of prostate cancer, these men are asymptomatic.
To perform a PSA test in these men therefore amounts to screening, which seems to be overlooked by general practitioners and urologists alike, even those who are clear that PSA screening is a bad idea. It could be argued that this group is particularly inappropriate for PSA testing as most will have benign prostatic hypertrophy, a common cause of PSA false positives. Educating patients is being put forward as the answer to salvaging a situation which has arisen because PSA testing is, like a mountain, "there." I think that this is only half the answer-we need to get our own house in order too, otherwise a retirement free of anxiety will be a thing of the past for most men.
Keith Hopcroft general practitioner
Laindon Health Centre, Laindon, Basildon, Essex SS15 5TR keithhopcroft@supanet.com majority of patients and professionals would not dream of stealing from the NHS. But a small minority of patients and health service staff are doing just that. Every time they commit fraud patients' care suffers. Those who are exploiting the system are not only cheating the taxpayers, they are depriving patients of the care they need," 3 said Alan Milburn MP; he is a fellow privy councillor of the lords who overturned the ruling of the General Medical Council that Dr K Manzur should be erased from the medical register.
The Manzur judgment has torpedoed the government's stance on fraud in the NHS, which drains millions away from frontline care each year. Privy councillors listening to appeals should perhaps be advised to take advice from their fellow privy councillors in the Cabinet as to what is or is not in the public interest.
The message sent out by the GMC was the correct one. Consultants hold a position of power and responsibility that demands trust when carrying out professional duties. They should expect that to abuse that position by lying, cheating, and committing fraud will result in erasure.
The GMC had marked the boundary of what was considered reasonable behaviour expected from a doctor. That is its responsibility as regulator of the profession. Contrary to what seems to be the belief of some politicians, journalists, and sections of the public, the GMC's professional conduct committee can make an unbiased decision that does not always favour the doctor. The external perception of the GMC is not helped by its good intentions being sabotaged by the Privy Council.
Would Mr Milburn really wish to condone senior NHS staff lying and taking money for personal gain, to the detriment of patient care, and then presenting financial accounts in such a way as to avoid being held to account for such behaviour? Fraud and dishonesty are unacceptable, and erasure was the correct course of action so as not to undermine "the integrity of doctors in the public's perception," as their lordships remarked during the proceedings. 4 Doctors should be held to the same standards as lawyers in their professional behaviour.
Nigel Dudley consultant in elderly medicine
St James's University Hospital, Leeds LS9 7TF Nigel.Dudley@leedsth.nhs.uk
